What is the current stock price of Gain Therapeutics, Inc.?

As of the latest update, Gain Therapeutics, Inc.'s stock is trading at $1.83 per share.

What's happening with Gain Therapeutics, Inc. stock today?

Today, Gain Therapeutics, Inc. stock is up by 4.86%, possibly due to recent market activity.

What is the market sentiment around Gain Therapeutics, Inc. stock?

Current sentiment around Gain Therapeutics, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is Gain Therapeutics, Inc.'s stock price growing?

Over the past month, Gain Therapeutics, Inc.'s stock price has increased by 0.82%.

How can I buy Gain Therapeutics, Inc. stock?

You can buy Gain Therapeutics, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol GANX.

Who are the major shareholders of Gain Therapeutics, Inc. stock?

Major shareholders of Gain Therapeutics, Inc. include institutions such as MW Group LP, Potomac Capital Management, Inc., The Jones Financial Companies LLLP, according to the latest filings.

GANX

Gain Therapeutics, Inc.

$1.83

4.86%

Trade Ideas Performance

Latest Closed Trade Idea

$1.83

4.86%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of Gain Therapeutics, Inc. (GANX)

Over the past six months, Gain Therapeutics' stock price has been influenced by several events. In December 2025, the company's price target was increased, and analysts reiterated "buy" recommendations. In January 2026, positive initial Phase 1b results for GT-02287 in Parkinson's disease were presented, showing a significant reduction in cerebrospinal fluid glucosylsphingosine levels and early clinical improvement signals. In March 2026, Gain Therapeutics reported its 2025 year-end financial results, including a net loss of $20.2 million and a cash balance of $20.8 million, while the stock gained approximately 5% since January 31, 2026, due to positive earnings surprises and encouraging Phase 1b clinical data. Despite these positive developments, the stock experienced a decline of 7.65% between May 8, 2025, and May 7, 2026. As of April 12, 2026, analysts gave the stock a consensus recommendation of "Moderate Buy" with an average twelve-month target price of $8.50.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community